Estradiol/progesterone - TherapeuticsMD
Alternative Names: 17β-estradiol/progesterone -TherapeuticsMD; BIJUVA; BIJUVE; E2/P4; Estradiol and progesterone; Progesterone/estradiol - TherapeuticsMD; TX 12-001-HR; TX-001HR; TX-001HR: BIJUVA™; TX-006HR; TX-008HR; TX-009HRLatest Information Update: 12 Feb 2024
At a glance
- Originator TherapeuticsMD
- Developer Knight Therapeutics; Theramex; TherapeuticsMD
- Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnenediones
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome
- Phase III Endometrial hyperplasia